AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Multicentric Clinical Investigation to Assess Safety and Performance of Lux HighAdd IOL

RecruitingNAAges 50 Years - anyAllCutting Edge SAS
💬

In plain words

What the trial is, and whether it could suit you

The study purpose is to demonstrate safety and performance of bilateral implantation of LuxHighAdd intraocular lens compared with the LuxGood Monofocal lens.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Subject aged 50 or over on the day of inclusion, presenting a bilateral cataract, qualified for bilateral implantation * No ocular comorbidity possibly affecting the study results * Fit within the available IOL diopter range * Have had no previous refractive surgery * Regular corneal astigmatism ≤1.0 dioptres * Clear intraocular media other than cataract * Availability, willingness and sufficient cognitive awareness to comply with examination procedures * Ability to attend all study follow-ups * Signed informed consent. Exclusion Criteria: * Ocular surface disease potentially affecting study results * Pre-existing ocular pathology or history of pathology potentially affecting the study results * Acute or chronic disease or illness that would increase risk or confound study results * Subjects who may be reasonably expected to require a secondary surgical intervention at any time during the investigation (other than YAG capsulotomy) * Axial lengths and keratometry such as the IOL spherical power is not in the range of 16 to 26 D * Instability of keratometry or biometry measurements * Traumatic cataract * Amblyopia * History of ocular trauma or any prior ocular surgery including refractive procedures * Capsular or zonular abnormalities that may affect postoperative centration or tilt of the lens * Pupil abnormalities * Systemic or ocular medication that could modify pupil dynamics * Expected complicated surgery or complicated surgery * Concurrent participation in another drug or device investigation
💊

What it tests

  • LuxHighAdd IOL
  • LuxGood IOL
📍

Where

3 sites
Centre d'Ophtalmologie des Dr Rozot et associés
Marseille, France
Clinique Honoré Cave
Montauban, France
Hôpital Fondation Adolphe de Rothschild
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy